Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies
Author:
Affiliation:
1. Department of Laboratory Medicine, University of Washington; Seattle Washington
2. Laboratory of Pathology, CCR, NIH; Bethesda Maryland
Funder
Council for Chemical Research
National Cancer Institute
National Institutes of Health
Publisher
Wiley
Subject
Medical Laboratory Technology,General Medicine,Histology,Biochemistry
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpcy.44/fullpdf
Reference25 articles.
1. Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equal;Acon-Laws;American Journal of Hematology,2011
2. FDA Approval of tisagenlecleucel: Promise and complexities of a $475,000 Cancer Drug;Bach;JAMA,2017
3. Monitoring minimal residual disease in acute leukemia: Technical challenges and interpretive complexities;Chen;Blood Reviews,2017
4. A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy;Cherian;Cytometry. Part B, Clinical Cytometry,2018
5. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy;Fry;Nature Medicine,2018
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines;Cytometry Part B: Clinical Cytometry;2024-08-21
2. Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia;HemaSphere;2024-07-29
3. Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy;Cytometry Part B: Clinical Cytometry;2024-01-19
4. Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update;Indian Journal of Hematology and Blood Transfusion;2023-09-16
5. Diagnostic Flow Cytometry in the Era of Targeted Therapies;Surgical Pathology Clinics;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3